hsa-mir-1271: Hsa-mir-1271 is a microRNA (miRNA) identified as unique to the platelet-derived fraction and is implicated in various biological processes and diseases [PMC3281076]. It has been found to target ATG16L, a gene associated with autophagy and inflammatory bowel disease (IBD) susceptibility [PMC3281076]. In the context of acute myocardial infarction (AMI) and healthy controls, hsa-mir-1271 is among the miRNAs with downregulated expression [PMC8923688]. It is pancreas-specific and targets the CTSB gene, which has non-coding variants [PMC6778667]. Hsa-mir-1271 also plays a role in cancer, where it is associated with resistance to cisplatin treatment [PMC8206191] and can influence the expression of CASP9, a gene involved in apoptosis, when silenced in cell cultures treated with salinomycin [PMC8206191]. Its expression levels fluctuate under salinomycin treatment, suggesting its role in cellular response mechanisms to chemotherapy [PMC8206191]. Additionally, hsa-mir-1271 has been identified as a potential diagnostic biomarker for malignant pleural mesothelioma (MPM), given its involvement in p38-related pathways which are crucial for tumorigenesis [PMC4464514].